The medical world was shocked when a major clinical study involving over 16,000 women came to a halt after five years because of the risks of heart disease, breast cancer, strokes, and blood clots found to occur. The study was intended to continue until 2005, but on May 31, 2002, the decision to end the study was decided by an expert panel. There were 6 million American women taking hormone replacement therapy at the time the study was released.
Hormone replacement therapy from hormone specialist Charlotte NC | SpartanMedicalAssociates had been a common prescription for women who had not had a hysterectomy to take when reaching menopause for decades, and the results of the study came as such a surprise to medical experts many doctors did not know what to tell their patients and they removed their phones from the hook when their phone lines became flooded with concerned women.
The nation’s largest study involving 16,000 women has come to an abrupt end prior to its intended 2005 finish date when new data showed hormone replacement therapy, the use of estrogen and progestin, increases the risk of breast cancer, heart attacks, strokes, and blood clots. The trial was the first and only large study comparing the effects of hormone replacement therapy with placebos in healthy women. The Women’s Health Initiative study results were released early because of the impact of the results that could affect the six million American women on hormone replacement therapy.
Up until the results of the study were released, medical authorities were telling doctors to encourage almost every single woman that had not had a hysterectomy to start taking hormone replacement therapy when reaching menopause. The estrogen-progestin combination had been a common prescription for decades leaving many questioning how it took so long for long-term hormone replacement therapy side effects to be discovered.